Alphalyse

Odense, Denmark Founded: 2002 • Age: 24 yrs Acquired By Fidelio Capital
Protein analysis services are provided for drug development acceleration.

About Alphalyse

Alphalyse is a Healthcare company based in Odense (Denmark) founded in 2002, and was acquired by Fidelio Capital in July 2025. Protein analysis services are provided for drug development acceleration. Alphalyse offers products and services including Host Cell Protein Analysis and Product Characterization. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Proteomics. Its legal entity is ALPHALYSE A/S.

Company details

Alphalyse was established in 2002 in Odense, Denmark, within the biotechnology sector. Protein analysis services are offered to aid drug development processes. Impurity analysis and protein characterization are performed via mass spectrometry techniques. Additional services include biopharmaceutical characterization, peptide mapping through mass spectrometry, host cell protein evaluation, and protein quantification in complex biological samples. Operations focus on analytical support for pharmaceutical research and manufacturing.

  • Headquarters Odense, Denmark
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website alphalyse.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Fidelio Capital (Jul 2025)
  • Legal Name Alphalyse A/S
Key Metrics

Products & Services of Alphalyse

Alphalyse offers a comprehensive portfolio of products and services, including Host Cell Protein Analysis and Product Characterization.

Host Cell Protein Analysis
Analytical Service

Identifies and quantifies impurities in biologic drugs for safety.

Product Characterization
Analytical Service

Characterizes proteins and impurities in vaccines and therapies.

Apps and channels of Alphalyse

its YouTube channel Alphalyse A/S has 148 subscribers and 30 videos.

Alphalyse A/S
YouTube 148 subscribers 30 videos Science & Technology
Open channel

Videos from Alphalyse

The most watched videos on Alphalyse's YouTube channel, Alphalyse A/S (148 subscribers). Click a video to play it here.

USP 1132.1 - New US Pharmacopeia chapter on residual HCP measurement in Biopharmaceuticals by MS
3.2K views
How often does Genmab experience problematic HCPs?
3K views
With ELISA-MS you don't need a null cell line to get the HCP coverage number
2.2K views
Genmab: The ELISA "Total HCP" number is arbitrary
919 views

More on Alphalyse A/S.

Funding Insights of Alphalyse

  • Total Rounds 4
  • Last Round Grant β€” $342,470
  • Investors Count 1

All 4 funding rounds of Alphalyse with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2017$342,470Grant––
Jan 2017$306,105Grant––
Nov 2016$290,000Grant––
–
Jun 2014Grant––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Alphalyse

Alphalyse has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Fidelio Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Fidelio Capital is engaged in global investment to transform businesses.
fideliocapital.comStockholm, Sweden
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Alphalyse

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Alphalyse

4 dated milestones of Alphalyse across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Alphalyse is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $342K.
  4. Exit Acquired by Fidelio Capital.

Web traffic of Alphalyse

The website of Alphalyse (alphalyse.com) receives about 2.9K visits a month.

  • Monthly visits
    2.9K
Similar websites

Websites whose visitors overlap most with Alphalyse. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
proteomefactory.com
proteomefactory.com
100%
–
aldevron.com
86%
12.5K#1,963,419View details
proteindesign.com
proteindesign.com
83%
–
eprogen.com
83%
View details
proteinatlas.org
proteinatlas.org
82%
#96,467–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Alphalyse

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Alphalyse

Premium access

Complete news archive for Alphalyse

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alphalyse

Alphalyse was founded in 2002 and raised its 1st funding round 12 years after it was founded.

Alphalyse is headquartered in Odense, Denmark.

Alphalyse was established in 2002 in Odense, Denmark, within the biotechnology sector. Protein analysis services are offered to aid drug development processes. Impurity analysis and protein characterization are performed via mass spectrometry techniques. Additional services include biopharmaceutical characterization, peptide mapping through mass spectrometry, host cell protein evaluation, and protein quantification in complex biological samples. Operations focus on analytical support for pharmaceutical research and manufacturing.

Alphalyse offers Host Cell Protein Analysis and Product Characterization.

Alphalyse has 2 investors. Key investors include European Union, and Fidelio Capital.

Alphalyse operates through Alphalyse A/S.

Yes. Alphalyse was acquired by Fidelio Capital in July 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available